Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 20,000 shares at $28.01 ($560K) on 2016-05-20, disclosed to the SEC on 2016-05-24.
Open-market sale of $560k ALDR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.01 | 2,986 | $84K | 14.9% |
| 2 | $28.01 | 2,986 | $84K | 14.9% |
| 3 | $28.01 | 2,997 | $84K | 15.0% |
| 4 | $28.01 | 2,997 | $84K | 15.0% |
| 5 | $28.03 | 4,017 | $113K | 20.1% |
| 6 | $28.03 | 4,017 |
| $113K |
| 20.1% |
| Total | $28.02 avg | 20,000 | $560K | 100% |
| Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-10-05 | $424K | — | Filing → |
| ALDR | SELL | 2016-09-06 | $650K | — | Filing → |